Search IDVs

75N95022D00017

Indefinite Delivery Contract

Overview

Government Description
Nida data, statistics, and clinical trial support center. The award supports a range of clinical trials and research activities focused on Substance Use Disorders (SUD), including implementation of Medication-Assisted Treatment for Opioid Use Disorder (MOUD) in diverse community settings, integrated care for severe infectious diseases and SUD among hospitalized patients, and studies evaluating interventions such as buprenorphine, naltrexone, and ketamine. Additional work includes statistical analysis for adjunct therapies, management and support for the Helping To End Addiction Long-Term (HEAL) initiative, and trials addressing retention, engagement, and recovery strategies in addiction treatment programs.
Pricing
Cost Plus Fixed Fee
Set Aside
None
Extent Competed
Full And Open Competition
Multiple / Single Award
Single Award
Who Can Use
Single Agency
Individual Order Limit
$44,313,082
Vehicle Ceiling
$44,313,082 (73% Used)
Related Opportunity
75N95022D00009
Analysis Notes
Place of Performance Largest percentage of work under issued task orders completed at: Rockville, Maryland 20850 United States.
Amendment Since initial award the Vehicle Ceiling has increased 42% from $31,154,646 to $44,313,082.
Subcontracting Plan This IDC has an Individual Subcontract Plan. The Department of Health and Human Services has an overall 2023 small business subcontracting goal of 32%
The Emmes Company was awarded Indefinite Delivery Contract 75N95022D00017 (75N950-22-D-00017) by National Institute on Drug Abuse for NIDA Data, Statistics, And Clinical Trial Support Center (DSC) in September 2022. The IDC has a duration of 5 years and was awarded full & open with NAICS 541715 and PSC AN11 via direct negotiation acquisition procedures with 3 bids received. To date, $32,240,279 has been obligated through this vehicle. The total ceiling is $44,313,082, of which 73% has been used.

Status
(Open)

Modified 3/2/26
Period of Performance
9/4/22
Start Date
9/4/27
Ordering Period End Date
76.0% Complete

Task Order Obligations
$32.2M
Total Obligated
$32.2M
Current Award
$32.2M
Potential Award
100% Funded

Award Hierarchy

Indefinite Delivery Contract

75N95022D00017

Contracts

-

Subcontracts

-

Federal Award Analysis

Historical federal task order obligations under 75N95022D00017

$-

Contracts

$-

Subcontracts

$-

Grants

$-

Subgrants

$-

Total

Interactive Stacked Bar Chart


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating
Year Contracts Subcontracts Grants Subgrants


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating

Contract Awards

Prime task orders awarded under 75N95022D00017

Subcontract Awards

Disclosed subcontracts for 75N95022D00017

Transaction History

Modifications to 75N95022D00017

People

Suggested agency contacts for 75N95022D00017

Competition

Number of Bidders
3
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Individual Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
NBQCBJ6FXBU4
Awardee CAGE
3EX59
Agency Detail
Awarding Office
75N950 NATIONAL INSTITUTES OF HEALTH NIDA
Funding Office
75N950 NATIONAL INSTITUTES OF HEALTH NIDA
Created By
hhsjlazarus
Last Modified By
hhsjlazarus
Approved By
hhsjlazarus

Legislative

Legislative Mandates
Labor Standards
Awardee District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Representative
Jamie Raskin

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute on Drug Abuse, National Institutes of Health, Health and Human Services (075-0893) Health research and training Advisory and assistance services (25.1) $16,423,306 100%
Last Modified: 3/2/26